Cargill leads fragmented nutraceuticals market as innovation race intensifies

The Business Research Company’s 2026 nutraceuticals market report says the sector remains highly fragmented, with Cargill leading global sales in 2024 and the top 10 players holding just 3% of revenue. The report points to rising competition around evidence-based ingredients, personalized nutrition and clean-label products, with Evonik among the companies pushing new launches.

Why it matters: - The nutraceuticals market is still highly fragmented, which leaves room for ingredient suppliers, supplement makers and wellness brands to win share through innovation rather than scale alone. - Demand is shifting toward targeted nutrition, scientifically supported health products and personalized wellness solutions. - That makes clinical validation, bioavailability and clean-label formulation more important for product differentiation and buyer trust.

What happened: - The Business Research Company released its Global Nutraceuticals Market Report 2026, covering market size, trends and forecasts for 2026-2035. - Cargill Incorporated led global sales in 2024 with a 1% market share. - The top 10 players accounted for 3% of total market revenue in 2024. - The report said the market includes global ingredient manufacturers, nutrition science companies and specialized health and wellness suppliers. - The report listed major companies including Abbott Laboratories, Ajinomoto Co. Inc., Archer-Daniels-Midland Company, BASF SE, Glanbia plc, Roquette Freres SA and Ingredion Incorporated.

The details: - Cargill’s food ingredients and bioindustrial division supplies plant-based proteins, specialty oils, fibers, texturizers and nutritional ingredients. - Those ingredients are used in dietary supplements, functional foods and beverages. - The report described the market as fragmented, supported by ingredient makers, nutritional product developers, contract manufacturers and regional wellness brands. - Major raw material suppliers include Koninklijke DSM-Firmenich AG, Kerry Group plc, Evonik Industries AG, Corbion N.V., Kemin Industries Inc. and Aker BioMarine ASA. - Major wholesalers and distributors include Univar Solutions Inc., Brenntag SE, DKSH Holding Ltd., IMCD N.V. and Barentz International B.V. - Major end users include Herbalife Ltd., Amway Corporation, NOW Health Group Inc., Danone S.A., Yakult Honsha Co. Ltd., PepsiCo Inc. and The Coca-Cola Company. - The report said leading players hold their positions through broad ingredient portfolios, research and development capabilities, global supply networks and relationships with food, beverage and supplement manufacturers. - The report highlighted evidence-based ingredient innovation as a key market trend. - In May 2024, Evonik Industries AG launched nutraceutical products at Vitafoods Europe 2024, including AvailOm omega-3 powder, a Boswellia serrata joint health concept, expanded IN VIVO BIOTICS synbiotic solutions and Healthberry anthocyanin ingredients in the U.S. market. - The report also pointed to strategies including personalized nutrition, plant-based functional ingredients, advanced delivery formats, clinical research investment and clean-label product innovation. - The report included new 2026 features such as market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspot infographics and updated graphics and tables. - The Business Research Company said it has published more than 30,000 reports across 27 industries and 60+ geographies. - The firm said its research draws on 1,500,000 datasets, secondary research and interviews with industry leaders.

Between the lines: - A 1% market leader in a market with only 3% concentration among the top 10 players suggests no single company controls the category. - That structure favors suppliers with differentiated ingredients, strong regulatory support and the ability to back claims with data. - The emphasis on clinically supported formulations signals that nutraceutical competition is moving closer to pharmaceutical-style proof points without leaving the consumer market.

What's next: - The report expects product innovation, strategic acquisitions and expansion into specialty nutrition to strengthen leading companies. - Companies are likely to keep investing in targeted health outcomes, ingredient traceability and sustainable sourcing. - The report’s forecast window runs through 2035, indicating a long runway for category shifts tied to consumer health preferences and preventive healthcare demand. - The full report is available here.

The bottom line: - Nutraceuticals remains a wide-open market where scientific validation and product innovation matter more than size alone.